Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Reexamination Certificate
2007-10-09
2007-10-09
Kifle, Bruck (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
Reexamination Certificate
active
11293353
ABSTRACT:
The present invention provides a process for the preparation of pimecrolimus from ascomycin in which ascomycin is reacted with a conversion reagent that converts ascomycin to its activated derivative at C-32. The activated ascomycin is then reacted with chloride ion. The process of the invention requires fewer process steps than prior art processes, and does not require the protection of the ascomycin C-24 hydroxyl group or the purification of the activated ascomycin derivative.
REFERENCES:
patent: 3244592 (1966-04-01), Arai et al.
patent: 6423722 (2002-07-01), Dosenbach et al.
patent: 6620325 (2003-09-01), Fuenfschilling et al.
patent: 6706727 (2004-03-01), Fleissner et al.
patent: 0 323 865 (1989-07-01), None
patent: 0 427 680 (1991-05-01), None
patent: 0 480 623 (1992-04-01), None
patent: 1 234 833 (2002-08-01), None
patent: WO 93/04679 (1993-03-01), None
patent: WO 93/18050 (1993-09-01), None
patent: WO 03/063821 (2003-08-01), None
patent: WO 03/063822 (2003-08-01), None
patent: WO 2004/089958 (2004-10-01), None
patent: WO 2005/010015 (2005-02-01), None
patent: WO 2005/117837 (2005-12-01), None
patent: WO 2006/031664 (2006-03-01), None
Griffiths, C.E., “Ascomycin: An Advance in the Management of Atopic Dermatitis.”British Journal of Dermatology, (2001) vol. 144, p. 679-681.
Kessler, H., et al., “Structure of Rapamycin: An NMR and Molecular-Dynamics Investigation” Helvetica Chimica Acta, (1993)vol. 76, p. 117-130.
Brittain, H.G. (Editor) “Polymorphism in Pharmaceutical Solids” Drugs and the Pharmaceutical Sciences vol. 95, (1999) Marcel Dekker, Inc. New York, New York.
Remington, J. P. (Editor) “The Science and Practice of Pharmacy”, vol. II, Chapter 92, “Oral Solid Dosage Forms”, p. 1615-1649 (1995) Mack Publishing Company, Easton, Pennsylvania.
Yu, L: “Amorphous Pharmaceutical Solids: Preparation, Characterization and Stabilization.” Advanced Drug Delivery Reviews, (2001) vol. 48, p. 27-42.
Gyollai Viktor
Szabo Csaba
Kenyon & Kenyon LLP
Kifle Bruck
TEVA Gyógyszergyár Zártkörüen Mük
LandOfFree
Methods of preparing pimecrolimus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of preparing pimecrolimus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of preparing pimecrolimus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3871885